PRediction of Outcomes and PERsonalized Radiotherapy by Biomarkers and Functional Imaging

NAActive, not recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 1, 2024

Primary Completion Date

May 31, 2028

Study Completion Date

May 31, 2028

Conditions
Rectal Cancer, Radiotherapy
Interventions
OTHER

Blood analysis

This is an experimental analysis on tissues (peripheral blood) and exploratory, which is why the enrollment of a limited number of patients has been planned. The results obtained from the study should not be considered conclusive but rather as generators of research hypotheses for potential subsequent studies to be conducted on larger populations. The qualitative and quantitative characteristics of the vesicles and their miRNA content will be analyzed descriptively.

Trial Locations (1)

40138

IRCCS Azienda Ospedaliero - Universitaria di Bologna, Bologna

All Listed Sponsors
lead

IRCCS Azienda Ospedaliero-Universitaria di Bologna

OTHER

NCT06730035 - PRediction of Outcomes and PERsonalized Radiotherapy by Biomarkers and Functional Imaging | Biotech Hunter | Biotech Hunter